Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses 877.7 M944.1 M 3.41 B Research & development —— — Operating income 84.8 M499 M 847.4 M Non-Operating Income, Total 37.2 M37.2 M 100.7 M Interest expense, net of interest capitalized 113.1 M96.4 M 470.3 M Non-Operating Income, excl. Interest Expenses -75.9 M-59.2 M -369.6 M Unusual income/expense —— — Pretax income 84.8 M499 M 847.4 M Equity in earnings —— — Taxes 25.2 M147.7 M 226.9 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 59.6 M351.3 M 620.5 M Discontinued operations —— — Net income 59.6 M351.3 M 620.5 M Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 59.6 M351.3 M 620.5 M Basic earnings per share (Basic EPS) 0.392.34 4.12 Diluted earnings per share (Diluted EPS) 0.392.33 4.1 Average basic shares outstanding 151.76 M150.13 M — Diluted shares outstanding 152.39 M150.65 M — EBITDA 169.2 M600.8 M 1.22 B EBIT 84.8 M499 M 847.4 M Cost of revenue 2.69 B2.65 B 10.38 B Other cost of goods sold —— — Depreciation & amortization (cash flow) 84.4 M101.8 M 368 M